Embolization vs surgery for chronic subdural hematoma
Part of Brain & nervous system, Heart & circulation, Injuries & trauma clinical trials.
This trial compares a newer, less invasive treatment (embolization) with traditional surgery to treat chronic subdural hematoma (a slow bleed on the brain). It aims to see which approach works better and has fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 40 and 90 years old.
- You have a chronic subdural hematoma that is at least 10 mm thick on a CT scan of the head.
- The CT scan was done within the last 7 days.
- You must be able to start treatment within 72 hours of being assigned by chance to one of the two treatments.
- You or your legal representative must agree to randomization and sign consent forms.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways to treat a chronic subdural hematoma (a long-lasting bleed between the brain and its covering): blocking a specific artery versus standard surgery to remove the blood. It may help you and your care team choose the safer and more effective option for your situation.
This trial studies a procedure called middle-meningeal-artery embolization, which blocks the blood supply to a chronic subdural hematoma (a slow-growing blood collection around the brain). It compares outcomes in people with one-sided versus both-sided bleeds, and aims to see if this less invasive treatment can help reduce the need for surgery or improve recovery.
This trial tests a procedure called middle meningeal artery embolization, which aims to stop the bleeding and reduce the fluid buildup from a chronic subdural hematoma. It may be an option for patients who have a hematoma at least 10mm thick and one or more risk factors such as older age, blood thinners, diabetes, or certain scan features.
This trial compares two surgical techniques—using a small endoscope (camera) versus a single burr hole—to drain blood from a chronic subdural hematoma (a slow bleed on the brain surface). The goal is to see which method leads to better recovery and fewer complications.
This trial tests whether adding a drug called bevacizumab (given through an artery in the brain) to a standard procedure called middle meningeal artery embolization (MMAE) helps treat chronic subdural hematoma (a collection of blood on the brain's surface) better than the procedure alone. The study is for people scheduled for MMAE who meet specific size and symptom criteria.
This trial looks at how well a procedure called middle meningeal artery embolization works for people with chronic subdural hematoma (a collection of old blood on the brain's surface). It uses specific materials to block the blood supply to the hematoma, which may help the body reabsorb it without surgery.
Hear when a new Chronic Subdural Hematoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.